ISRG Intuitive Surgicaldata gap · 96% coverage
Health Care · Health Care Equipment · close $426.70 (2026-10-16) · latest quarter in EDGAR: 2026-06-30
Intuitive Surgical (ISRG) has a ThetaGrade House Rating of 59/100 (grade C), ranking #11 of 150 in Health Care. Its strongest pillars are balance sheet (78) and profitability (70); its weakest is valuation (22). Data gap: 1 factor without usable data, so 96% of the method weight is covered. TTM revenue growth is 20.7% and operating margin 31.3%.
Data as of .
Data gap
No usable data for: Interest coverage. Data gap: no usable data for this factor, so it is left out and its weight is shared among the factors that do have data (no value is imputed). 96% of the full method weight is backed by data.
Analyst sentiment
weight 7.5% · 50| Consensus score (1–5) (3.8%) | derived | 51 |
| 90-day net rating shift (3.8%) | derived | 70 |
Growth
weight 30.83% · 57| Revenue growth YoY (TTM) (12.3%) | 20.7% | 74 |
| EPS growth YoY (TTM) (12.3%) | 21.3% | 59 |
| Revenue acceleration (6.2%) | -4.4% | 20 |
Profitability
weight 18.5% · 70| Operating margin (9.9%) | 31.3% | 89 |
| 4Q gross-margin change (8.6%) | 0.1% | 49 |
Balance sheet
weight 18.5% · 78| Net debt / EBITDA (12.3%) | -0.68× | 79 |
| Current ratio (6.2%) | 4.96 | 77 |
| Interest coverage (0.0%)data gap | — | — |
Cash flow
weight 12.33% · 62| FCF margin (6.2%) | 24.7% | 84 |
| FCF yield (6.2%) | 1.7% | 39 |
Valuation
weight 12.33% · 22| P/E (inverted) (6.2%) | 48.99× | 23 |
| EV/Sales (inverted) (6.2%) | 13.41× | 20 |
Technicals (EOD)
| RSI(14) | 64.7 |
| EMA 9 / 21 | 420.22 / 409.84 |
| 200-day SMA | 439.63 |
| Volume vs 20d avg | 1.25× |
| 20-day return | 11.3% |
Exit-rule monitor
- EXITRating break: House Rating below 60
- WATCHTrend: close below 200-day average
Data source per metric (SEC XBRL tag or derivation): Revenue: RevenueFromContractWithCustomerExcludingAssessedTax · Gross profit: GrossProfit · Operating income: OperatingIncomeLoss · D&A: Depreciation · EPS: EarningsPerShareDiluted · Market cap: SEC shares (dei EntityCommonStockSharesOutstanding (cover page)) × EOD close · P/E: EOD close ÷ SEC TTM EPS (EarningsPerShareDiluted).
Get rating changes like ISRG's in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium (waitlist).
FAQ
- What is ISRG's House Rating?
- ISRG scores 59 out of 100 (grade C) as of 2026-10-16, ranking #11 of 150 Health Care stocks we cover.
- What do analysts say about ISRG?
- ThetaGrade's analyst-sentiment pillar for ISRG scores 50/100 against its sector peers, which we read as mixed. This is our own derived score; we do not republish individual analyst ratings, counts or targets.
- When does ISRG report earnings next?
- We do not have a reliable estimate for ISRG's next earnings date (irregular SEC filing history); a rough window is 2026-07-23 to 2027-01-17. Check the company's investor-relations page.
- Is ISRG a buy?
- ThetaGrade does not give personal advice. The House Rating is an educational, rules-based summary of public data; see the methodology for how it is built.
Sources: SEC EDGAR filings (fetched 2026-10-18), Finnhub recommendation trends, Massive EOD prices. Scores are sector percentiles; a factor without usable data is a data gap: it is left out and the remaining weights are renormalized (nothing is imputed). Educational only. Methodology